|
Since the beginning of 2020, the world has experienced an unprecedented health crisis. In the early stages of pandemic our only defense was extreme lockdown measures to protect citizens from the spread of the virus. Very quickly attention turned to the life science community to develop diagnostics, therapeutics and vaccines, and mitigate the human, economic and social harm that COVID-19 had caused world-wide.
The research-based pharmaceutical industry responded to this crisis at an extraordinary pace, developing safe and effective vaccines in an incredibly short time-frame. The response underlined the need for a strong pharmaceutical sector, able to (...)
|
